Tags

Type your tag names separated by a space and hit enter

Effects of the COVID-19 pandemic on supply and use of blood for transfusion.
Lancet Haematol. 2020 Oct; 7(10):e756-e764.LH

Abstract

The COVID-19 pandemic has major implications for blood transfusion. There are uncertain patterns of demand, and transfusion institutions need to plan for reductions in donations and loss of crucial staff because of sickness and public health restrictions. We systematically searched for relevant studies addressing the transfusion chain-from donor, through collection and processing, to patients-to provide a synthesis of the published literature and guidance during times of potential or actual shortage. A reduction in donor numbers has largely been matched by reductions in demand for transfusion. Contingency planning includes prioritisation policies for patients in the event of predicted shortage. A range of strategies maintain ongoing equitable access to blood for transfusion during the pandemic, in addition to providing new therapies such as convalescent plasma. Sharing experience and developing expert consensus on the basis of evolving publications will help transfusion services and hospitals in countries at different stages in the pandemic.

Authors+Show Affiliations

Transfusion Medicine, NHS Blood and Transplant, Oxford, UK; Department of Haematology, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, UK; Radcliffe Department of Medicine and NIHR Oxford Biomedical Research Centre-Haematology Theme, University of Oxford, Oxford, UK. Electronic address: simon.stanworth@nhsbt.nhs.uk.NHS Blood and Transplant, London, UK; Department of Haematology, Imperial College London, London, UK.Department of Immunology and Transfusion Medicine, Haukeland University Hospital, Bergen, Norway; Norwegian Armed Forces Medical Services, Oslo, Norway.Systematic Review Initiative, NHS Blood and Transplant, Oxford, UK.NHS Blood and Transplant, Cambridge, UK; Department of Haematology, University of Cambridge, Cambridge, UK.Systematic Review Initiative, NHS Blood and Transplant, Oxford, UK.Medical Affairs and Innovation, Héma-Québec, Québec, QC, Canada.Medical Affairs and Innovation, Canadian Blood Services, Ottawa, ON, Canada.NHS Blood and Transplant, Bristol, UK.Department of Transfusion Medicine and Hematology, IRCCS Ca 'Granda Hospital Maggiore Policlinico Foundation, Milan, Italy.Department of Medicine, Division of Haematology, Mount Sinai Hospital, ON, Canada; Department of Medicine, and Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, ON, Canada; University Health Network, Department of Medicine, Division of Medical Oncology and Haematology, Toronto, ON, Canada.Department of Transfusion Medicine, Sanquin Blood Supply Foundation, Amsterdam, Netherlands; Department of Haematology, Erasmus Medical Center, Rotterdam, Netherlands.Manchester University NHS Foundation Trust, Manchester, UK.

Pub Type(s)

Journal Article
Systematic Review

Language

eng

PubMed ID

32628911

Citation

Stanworth, Simon J., et al. "Effects of the COVID-19 Pandemic On Supply and Use of Blood for Transfusion." The Lancet. Haematology, vol. 7, no. 10, 2020, pp. e756-e764.
Stanworth SJ, New HV, Apelseth TO, et al. Effects of the COVID-19 pandemic on supply and use of blood for transfusion. Lancet Haematol. 2020;7(10):e756-e764.
Stanworth, S. J., New, H. V., Apelseth, T. O., Brunskill, S., Cardigan, R., Doree, C., Germain, M., Goldman, M., Massey, E., Prati, D., Shehata, N., So-Osman, C., & Thachil, J. (2020). Effects of the COVID-19 pandemic on supply and use of blood for transfusion. The Lancet. Haematology, 7(10), e756-e764. https://doi.org/10.1016/S2352-3026(20)30186-1
Stanworth SJ, et al. Effects of the COVID-19 Pandemic On Supply and Use of Blood for Transfusion. Lancet Haematol. 2020;7(10):e756-e764. PubMed PMID: 32628911.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Effects of the COVID-19 pandemic on supply and use of blood for transfusion. AU - Stanworth,Simon J, AU - New,Helen V, AU - Apelseth,Torunn O, AU - Brunskill,Susan, AU - Cardigan,Rebecca, AU - Doree,Carolyn, AU - Germain,Marc, AU - Goldman,Mindy, AU - Massey,Edwin, AU - Prati,Daniele, AU - Shehata,Nadine, AU - So-Osman,Cynthia, AU - Thachil,Jecko, Y1 - 2020/07/03/ PY - 2020/05/19/received PY - 2020/06/05/revised PY - 2020/06/08/accepted PY - 2020/7/7/pubmed PY - 2020/10/3/medline PY - 2020/7/7/entrez SP - e756 EP - e764 JF - The Lancet. Haematology JO - Lancet Haematol VL - 7 IS - 10 N2 - The COVID-19 pandemic has major implications for blood transfusion. There are uncertain patterns of demand, and transfusion institutions need to plan for reductions in donations and loss of crucial staff because of sickness and public health restrictions. We systematically searched for relevant studies addressing the transfusion chain-from donor, through collection and processing, to patients-to provide a synthesis of the published literature and guidance during times of potential or actual shortage. A reduction in donor numbers has largely been matched by reductions in demand for transfusion. Contingency planning includes prioritisation policies for patients in the event of predicted shortage. A range of strategies maintain ongoing equitable access to blood for transfusion during the pandemic, in addition to providing new therapies such as convalescent plasma. Sharing experience and developing expert consensus on the basis of evolving publications will help transfusion services and hospitals in countries at different stages in the pandemic. SN - 2352-3026 UR - https://www.unboundmedicine.com/medline/citation/32628911/Effects_of_the_COVID_19_pandemic_on_supply_and_use_of_blood_for_transfusion_ DB - PRIME DP - Unbound Medicine ER -